Clinical Management and Outcome of Grade III Pneumonitis after Chemoradioimmunotherapy for Inoperable Stage III Non-Small Cell Lung Cancer—A Prospective Longitudinal Assessment

Clinical Management and Outcome of Grade III Pneumonitis after Chemoradioimmunotherapy for Inoperable Stage III Non-Small Cell Lung Cancer—A Prospective Longitudinal Assessment

Background: Maintenance treatment with immune-checkpoint inhibition (ICI) has been shown to significantly improve patient prognosis after chemoradiotherapy (CRT) for inoperable stage III NSCLC. This survival advantage may be achieved at the expense of an increased probability for symptomatic pneumon...

Full description

Bibliographic Details
Main Authors: Diego Kauffmann-Guerrero, Julian Taugner, Chukwuka Eze, Lukas Käsmann, Minglun Li, Amanda Tufman, Farkhad Manapov
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Diagnostics
Subjects:
chemoradioimmunotherapy
NSCLC
pneumonitis
lung function
immunotherapy
Online Access:https://www.mdpi.com/2075-4418/11/11/1968

Internet

https://www.mdpi.com/2075-4418/11/11/1968

Similar Items